Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $3.5 million.

  • InspireMD's Share-based Compensation rose 4506.75% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 2530.45%. This contributed to the annual value of $10.1 million for FY2024, which is 12579.06% up from last year.
  • Latest data reveals that InspireMD reported Share-based Compensation of $3.5 million as of Q3 2025, which was up 4506.75% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, InspireMD's Share-based Compensation ranged from a high of $3.5 million in Q3 2025 and a low of $289000.0 during Q1 2023
  • For the 5-year period, InspireMD's Share-based Compensation averaged around $1.5 million, with its median value being $930000.0 (2023).
  • Its Share-based Compensation has fluctuated over the past 5 years, first plummeted by 5574.27% in 2023, then surged by 80588.24% in 2024.
  • Quarter analysis of 5 years shows InspireMD's Share-based Compensation stood at $566000.0 in 2021, then tumbled by 34.98% to $368000.0 in 2022, then surged by 348.1% to $1.6 million in 2023, then surged by 42.27% to $2.3 million in 2024, then surged by 51.07% to $3.5 million in 2025.
  • Its Share-based Compensation was $3.5 million in Q3 2025, compared to $3.2 million in Q2 2025 and $2.7 million in Q1 2025.